KaydedilenlerDerginizi ekleyin

Dergiler / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 5

Warfarin Treatment: Home Health Services VersusOutpatient Clinics

Sonay ÖZDEMİR
Pelin ÜNSAL
Sayfa
438–442
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: The patients followed by HHS were older (78 vs. 68, p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Warfarin use is difficult due to the necessity for regular international normalized ratio (INR) monitoring and drug– drug interaction.
📊
Temel Bulgular & Veri:Materials and Methods: This study included 204 patients followed by OC and HHS and receiving warfarin treatment.Demographic and clinical characteristics and INR monitoring frequency were evaluated.
💡
Sonuç & Katkı:Results: The patients followed by HHS were older (78 vs. 68, p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Warfarin use is difficult due to the necessity for regular international normalized ratio (INR) monitoring and drug– drug interaction. However, it is still the most widely preferred oral anticoagulant. This study aimed to assess the efficacy andreliability of warfarin use by patients attending outpatient clinics (OC) or who received home health services (HHS). Materials and Methods: This study included 204 patients followed by OC and HHS and receiving warfarin treatment.Demographic and clinical characteristics and INR monitoring frequency were evaluated. Moreover, complications wereretrospectively questioned. The interactions between warfarin use and other medications were assessed. Hypertension,Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs/alcohol (HAS-BLED)and Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) scores were calculated in the atrial fibrillation (AF) group. Results: The patients followed by HHS were older (78 vs. 68, p

🔖

Bu Makaleye Atıf Yap

ÖZDEMİR, S., ÜNSAL, P. (2022). Warfarin Treatment: Home Health Services VersusOutpatient Clinics. Erciyes Medical Journal, Cilt: 43 - Sayı: 5, 438–442. https://ajindex.com/articles/502198

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Pirmohamed M. Warfarin: the end or the end of one size fits all therapy? J Pers Med 2018; 8(3): 22
  2. Kılıç S, Çelik A, Çakmak HA, Afşin A, Tekkeşin Aİ, Açıksarı G, et al. The time in therapeutic range and bleeding complications of warfarin in different geographic regions of Turkey: A subgroup analysis of WARFARIN-TR study. Balkan Med J 2017; 34(4): 349–55
  3. Çayır Y. Home health services in primary care: What can we do? Dicle Med J 2013; 40(2): 340–4
  4. Heneghan CJ, Garcia-Alamino JM, Spencer EA, Ward AM, Perera R, Bankhead C, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2016; 7(7): CD003839
  5. Ozturk M, Ipekci A, Kiyak SK, Akdeniz YS, Aydin Y, Ikizceli I, et al. Bleeding complications in Warfarin-Treated patients admitted to the emergency department. J Clin Med Res 2019; 11(2): 106–13
  6. Vazquez SR. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Hematology Am Soc Hematol Educ Program 2018; 2018(1): 339–47
  7. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138(5): 1093–100
  8. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011; 58(4): 395–401
  9. Teruel RS, Thue G, Fylkesnes SI, Sandberg S, Kristoffersen AH. Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements? Scand J Prim Health Care 2017; 35(3): 299–306
  10. National Institute for Health and Care Excellence (NICE). Atrial fibrillation and heart valve disease: self-monitoring coagulation status using pointof-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor). Available from: URL: https://www.nice. org.uk/guidance/dg14/resources/atrial-fibrillation-and-heart-valve-disease-selfmonitoring-coagulation-status-using-pointofcare-coagulometers-the-coaguchek-xs-system-pdf-1053629789893. Accessed, 19 December, 2017
  11. McAuliffe GN, De Silva F, Upton A, Chan G. International normalised ratio monitoring in the community populations of the Auckland and Northland regions of New Zealand: time in therapeutic range and frequency of testing. Intern Med